In this open-treatment , international , randomized , controlled trial , ischemic stroke patients were randomly allocated < 6 hours of onset to intravenous alteplase ( 0.9 mg/kg ) plus standard care ( n = 1515 ) or standard care alone ( n = 1520 ) .